The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma

The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma

Show other versions (1)

This study aimed to evaluate treatment results in patients with diffuse large cell lymphoma (DBL CL) received R-CHOP program (as 1 st and2 nd line therapy), including cases with complications. We observed 77 DBLCL patients (50 primary and 27 received other chemotherapy programs, in relapse, progress...

Full description

Bibliographic Details
Main Authors:	T. D. Lutskaya, A. K. Golenkov, T. A. Mitina, I. V. Buravtsova, G. A. Dudina, L. L. Vysotskaya, E. V. Trifonova, E. V. Kataeva, O. V. Moskalets, V. V. Yazdovskiy
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Онкогематология
Subjects:	diffuse b-large cells lymphoma rituximab
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/86

Similar Items

The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma
by: T. D. Lutskaya, et al.
Published: (2014-07-01)

Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience
by: Murat Özbalak, et al.
Published: (2022-11-01)

Clinical significance of rituximab infusion-related reaction in diffuse large B-cell lymphoma patients receiving R-CHOP
by: Kyoung Min Cho, et al.
Published: (2019-07-01)

A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA
by: Laurie H. Sehn, et al.
Published: (2020-06-01)

Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R‐CHOP
by: Vít Procházka, et al.
Published: (2020-07-01)

Intravitreal rituximab for the treatment of a secondary intraocular relapse of a large B-cell lymphoma
by: Jose J. Echegaray, et al.
Published: (2018-03-01)

Identification and overcoming rituximab resistance in diffuse large B-cell lymphoma using next-generation sequencing
by: Min Ji Jeon, et al.
Published: (2023-11-01)

Rituximab in the treatment of nodal Bcell marginal zone lymphoma, primary Sjogren’s syndrome and autoimmune hepatitis
by: O A Logvinenko, et al.
Published: (2008-10-01)

Addition of Rituximab Significantly Improves Outcomes in Patients with Diffuse Large B-cell Lymphoma – a Single-center, Retrospective Study
by: David Belada, et al.
Published: (2007-01-01)

Rituximab therapy for systemic manifestations and MALT lymphomas of the parotid gland in Sjögren's disease: Preliminary data
by: O A Logvinenko, et al.
Published: (2012-12-01)

Role of radiotherapy in diffuse large B‐cell lymphoma in advanced stages on complete response after administration of cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab
by: Agustin Aviles, et al.
Published: (2019-09-01)

Combined chemoimmunotherapy of patients with mature B-cell non-Hodgkin lymphomas age group until 18 years: results of multicenter study NHL 2004 m with rituximab and modified B-NHL BFM 90 protocol applications
by: E. V. Samochatova, et al.
Published: (2022-11-01)

Experience of using rituximab for recurrent non-Hodgkin lymphoma in elderly patients of the Orel region
by: R. A. Golubenko, et al.
Published: (2014-07-01)

Experience of using rituximab for recurrent non-Hodgkin lymphoma in elderly patients of the Orel region
by: R. A. Golubenko, et al.
Published: (2014-07-01)

Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
by: E. V. Kataeva, et al.
Published: (2014-07-01)

Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
by: E. V. Kataeva, et al.
Published: (2014-07-01)

An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era
by: Feifei Sun, et al.
Published: (2018-01-01)

The Role of Rituximab in Lymphomas
by: Bertrand Coiffier
Published: (2002-01-01)

Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience
by: Roland Christian Schelker, et al.
Published: (2018-10-01)

Rituximab Treatment Strategy for Patients with Diffuse Large B-Cell Lymphoma after First-Line Therapy: A Systematic Review and Meta-Analysis
by: Yuan-Rong Ren, et al.
Published: (2015-01-01)

Intralesional and systemic rituximab in the treatment of primary cutaneous B‐cell lymphoma
by: Jake G. Besch‐Stokes, et al.
Published: (2023-12-01)

CHOP-like Regimen in Combination with Rituximab and Peginterferon Alpha-2b in Newly-diagnosed Diffuse Large B-cell Non-Hodgkin’s Lymphoma: Experience in a Chinese Center
by: Shu-qing LV, Jian-min YANG, Xian-min SONG, Li CHEN, Wei-ping ZHANG, Xiao-qian XU, Xiong NI, Chong-mei HUANG, Yi HE, Jian-min WANG, et al.
Published: (2010-04-01)

Change of CD20 Expression in Diffuse Large B-Cell Lymphoma Treated with Rituximab, an Anti-CD20 Monoclonal Antibody: A Study of the Osaka Lymphoma Study Group
by: Naoki Wada, et al.
Published: (2009-10-01)

Linfoma hepático primario: Evolución favorable con quimioterapia combinada con rituximab Primary hepatic lymphoma: favorable outcome with chemotherapy plus rituximab
by: I. Serrano-Navarro, et al.
Published: (2008-11-01)

Primary diffuse large B-cell lymphoma of the central nervous system (case report and literature review)
by: K. A. Komratova, et al.
Published: (2017-04-01)

A phase III, multicentric, open-label, two-arm, parallel group, active-control, randomized, comparative clinical study to evaluate efficacy and safety of RituxiRel™ arm (rituximab) with reference arm (rituximab) in patients with non-Hodgkin's lymphoma
by: Prasad Dattatray Apsangikar, et al.
Published: (2017-01-01)

Adding rituximab to chemotherapy for diffuse large B-cell lymphoma patients in Indonesia: a cost utility and budget impact analysis
by: Septiara Putri, et al.
Published: (2022-04-01)

The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B‐cell lymphoma
by: Steven Habbous, et al.
Published: (2020-10-01)

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma
by: K. Lisenko, et al.
Published: (2017-05-01)

Diffuse large B-cell lymphoma: An institutional analysis
by: Ajay Gogia, et al.
Published: (2018-01-01)

A phase II study of lenalidomide and rituximab (R2) combination in patients with high-risk refractory/relapsed diffuse large B-cell lymphoma
by: Robin Noel, et al.
Published: (2023-12-01)

Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi
by: Gloria Margiotta-Casaluci, et al.
Published: (2023-03-01)

TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP
by: Yalu Liu, et al.
Published: (2017-11-01)

Modified Stage Grouping of Diffuse Large B-Cell Lymphoma Involving the Same Side of the Diaphragm in the Rituximab Era
by: Hyehyun Jeong, et al.
Published: (2022-05-01)

The beneficial effect of Escalated‐R‐CHOP‐21 for the treatment of diffuse large B‐cell lymphoma in elderly male patients: A propensity‐matched cohort study
by: Hai‐Xia He, et al.
Published: (2021-11-01)

Phase II study of dose‐adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B‐cell lymphoma patients
by: Satoshi Yamasaki, et al.
Published: (2020-11-01)

Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non‐interventional study MabSCale
by: Jan Dürig, et al.
Published: (2023-02-01)

Primary breast lymphoma: A single-institute experience in Taiwan
by: Che-Wei Ou, et al.
Published: (2014-10-01)

Rituximab Maintenance Strategy in Advanced Follicular Lymphoma: Facts and Controversies
by: Vibor Milunović, et al.
Published: (2017-01-01)

Results of CHOP chemotherapy for diffuse large B-cell lymphoma
by: A.E. Hallack Neto, et al.
Published: (2006-10-01)